Login / Signup

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Bhairavi SwaminathanGuðmar ThorleifssonMagnus JöudMina AliEllinor JohnssonRam AjorePatrick SulemBritt-Marie HalvarssonGuðmundur EyjolfssonVilhelmina HaraldsdottirChristina HultmanErik IngelssonSigurður Y KristinssonAnna K KählerStig LenhoffGisli MassonUlf-Henrik MellqvistRobert MånssonSven NelanderIsleifur OlafssonOlof SigurðardottirHlif SteingrimsdóttirAnnette VangstedUlla VogelAnders WaageHareth NahiDaniel F GudbjartssonThorunn RafnarIngemar TuressonUrban GullbergKári StefánssonMarkus HanssonUnnur ThorsteinsdóttirBjörn Nilsson
Published in: Nature communications (2015)
Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genome-wide association study in the Nordic region identifying a novel MM risk locus at ELL2 (rs56219066T; odds ratio (OR)=1.25; P=9.6 × 10(-10)). This gene encodes a stoichiometrically limiting component of the super-elongation complex that drives secretory-specific immunoglobulin mRNA production and transcriptional regulation in plasma cells. We find that the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (P=8.6 × 10(-9) and P=6.4 × 10(-3), respectively) and, potentially, with an increased risk of bacterial meningitis (OR=1.30; P=0.0024).
Keyphrases
  • multiple myeloma
  • induced apoptosis
  • genome wide association study
  • copy number
  • cell cycle arrest
  • genome wide
  • oxidative stress
  • signaling pathway
  • endoplasmic reticulum stress
  • cell proliferation